Sustainability Report And Environmental, Social And Governance Report (Chinese edition)

Overview

The report presents Shanghai Pharma's 2022 sustainability performance, with the board responsible for ESG strategy and reporting. It highlights rare-disease access, including over 1.22亿 pills supplied for nearly 11.5万 patients. The workforce totaled 47,877 and recorded zero work-related fatalities, while environmental highlights included eight national green factories and one zero-carbon factory.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: Chinese
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services